• Abdul Jabbar Pirzada
  • Adeel Anwar
  • Atif Javed
  • Imran Memon
  • Ariz Mohammad


Background: Renal stone disease is a significant and worldwide health problem. Recent advances instone management have allowed kidney stones to be treated using extracorporeal shock wavelithotripsy (ESWL), uretero-renoscopy (URS), and percutaneous nephrostolithotomy (PCNL).Recently, medical expulsion therapy (MET) has been investigated as a supplement to observation in aneffort to improve spontaneous stone passage rates. Patients and Methods: This study was arandomized, controlled, prospective study to determine whether the administration of Alpha-1-adrenergic receptor antagonists as an adjunctive medical therapy, increases the efficacy of ESWL totreat renal stones. Sixty patients with renal stones of 0.5–1.5 Cm in size (average size 1.2 Cm) wereincluded in this study underwent ESWL followed by administration of Alpha-1-adrenergic receptorantagonists at department of Urology Liaquat National Hospital Karachi from Feb 2008 to Sept 2008.This was a comparative study and patients were divided into two groups. In group A patients receivedconventional treatment Diclofenac sodium, Anti Spasmodic (Drotverine HCl) as required and ProtonPump inhibitor (Omeprazole 20 mg) once daily after shock wave lithotripsy. In group B patientsreceived alpha-1 blocker, Alfuzosin HCl 5 mg twice daily in addition to conventional treatment. Allpatients were instructed to drink a minimum of 2 litres water daily. Ultrasound guided Dornier AlphaImpact Lithotripter was utilised for shock wave lithotripsy. Results: Of the 60 patients, 76.7% of thosereceiving Alfuzosin and 46.7% of controls had achieved clinical success at 1 month (p=0.01). Themean cumulative diclofenac dose was 485 mg per patient in the Alfuzosin group and 768 mg perpatient in the control group (p=0.002). This difference was statistically significant. Conclusion:Alfuzosin therapy as an adjunctive medical therapy after ESWL is more effective than lithotripsy alonefor the treatment of patients with large renal stones and is equally safe. It increases the expulsion ratesof stones, decreases time to expulsion, and decreases need for analgesia during stone passage.Keywords: Alpha-blockers, Ureteral stones, Kidney stones, ESWL


Gravina G L, Costa A M, Ronchi P, Galatioto G P, Angelucci A,

Castellani D, et al. Tamsulosin treatment increases clinical

success rate of single extracorporeal shock wave lithotripsy of

renal stones. Urology 2005;66:24–8.

Chaussy C, Schiedt, Jocham D, Brendel W, Forssmann B,

Walther V. First Clinical experience with extracorporeal induced

destruction of kidney stones by shock waves. J Urol


Newsame JE, Rintoul RF. The kidney, adrenal and ureter.

Farquharson’s text book of operative surgery. 7th ed. New York

(NY): Churchill Livingstone; 1986.p 528–73.

Marshall FF, Weiskopf F, Singh A, Mark F, Leo F, Sanders R, et

al. A prototype device for nomimmersion shock wave lithotripsy

using ultrasonography for calculus localization. J Urol


Khan FA. Basic data on urinary stones in Pakistan. Bulletin


Conort P, Dore B, Saussine C. Guidelines for the urological

management of renal and ureteric stones in adults. Prog Urol


Bajwa IA, Mahmood S, Ahmad I, Hussain S. In Situ

Extracorporeal Shock Wave Lithotripsy in the Management of

Ureteric Calculi. Ann King Edward Med Coll 2002;8:113–6.

Malin JM, Deane RF, Boyarsky S. Characterisation of adrenergic

receptors in human ureter. Br J Urol 1970;42:171–4.

Hollingsworth JM, Rogers MA, Kaufman SR, Bradford TJ, Saint

S, Wei JT, et al. Medical therapy to facilitate urinary stone

passage: a meta-analysis. Lancet 2006;368:1171–9.

Teichman JM Clinical practice. Acute renal colic from ureteral

calculus. N Engl J Med 2004;350(7):684–93.

Dellabella M, Milanese G, Muzzonigro G. Efficacy of tamsulosin

in the medical management of juxtavesical ureteral stones. J Urol


Dellabella M, Milanese G, Muzzonigro G. Medical-expulsive

therapy for distal ureterolithiasis: randomized prospective study

on role of corticosteroids used in combination with tamsulosinsimplified treatment regimen and health-related quality of life.

Urology 2005;66:712.

Lepor H. Advances in Alpha-Blocker Therapy in the

Management of Urological Disorders Rev Urol 2006;8(4):S1–2.

Kupeli B, Irkilata L, Gurocak S, Tunc L, Kirac M, Karaoglan U, et

al. Does tamsulosin enhance lower ureteral stone clearance with or

without shock wave lithotripsy? Urology 2004;65:1111–5.

Gravina GL, Costa AM, Ronchi P, Galatioto GP, Angelucci A,

Castellani D, et al. Tamsulosin treatment increases clinical

success rate of single extracorporeal shock wave lithotripsy of

renal stones. Urology 2005;66:24–8.

Deliveliotis C, Chrisofos M, Gougousis E, Papatsoris A, Dellis

A, Varkarakis IM. Is there a role for alpha1-blockers in treating

double-J stent-related symptoms? Urology 2006;67:35–9.

J Ayub Med Coll Abbottabad 2011;23(2) 129

Coll DM, Varanelli MJ, Smith RC: Relationship of spontaneous

passage of ureteral calculi to stone size and location as revealed

by unenhanced helical CT. AJR Am J Roentgenol 2002;178:101.

Borghi L, Meschi T, Amato F, Novarini A, Giannini A,

Quarantelli C, et al. Nifedipine and methylprednisolone in

facilitating ureteral stone passage. J Urol 1994;152:1095–8.

Blair B, Fabrizio M. Pharmacology for renal calculi. Expert Opin

Pharmacother 2000;1:435–41.

Cervenakov I, Fillo J, Mardiak J. Speedy elimination of

ureterolithiasis in lower part of ureter with the alpha-1-blockertamsulosin. Int Urol Nephrol 2002;34:25–9.

Sigala S, Dellabella M, Milanese G, Fornari S, Faccoli S,

Palazzolo F, et al. Evidence for the presence of alpha1

adrenoceptor subtypes in the human ureter. Neurourol

Urodynamics. 2005;24:142–8.

Lingeman JE, Siegel YI, Steele B, Nyhuis AW, Woods JR.

Management of lower pole nephrolithiasis: a critical analysis. J

Urol 1994;151:663–7.